REQUESTING THE AUDITOR TO ASSESS THE SOCIAL AND FINANCIAL EFFECTS OF MANDATORY HEALTH INSURANCE COVERAGE FOR BIOMARKER TESTING.

SCR 29 is a Senate Concurrent Resolution requesting the State Auditor assess the social and financial effects of mandatory health insurance coverage for biomarker testing. It directly affects patients with conditions like cancer, Alzheimer's, or heart disease who rely on biomarker tests for diagnosis and treatment. The resolution asks for a new assessment because, despite prior reports finding no impacts (as insurers claimed existing coverage already met requirements), patients still face delays or denials of coverage for these tests. The Auditor will evaluate how mandatory coverage would affect access, costs, and outcomes for patients seeking medically necessary biomarker testing.